HSIC.NASDAQHenry Schein INC

Form 4: Henry Schein Exec's Stock Vesting & Tax Withholding

Sentiment:

Insider Transaction Report


Christine Zayac Sheehy, SVP and Chief Human Resources Officer at Henry Schein, reported the vesting of 780 performance-based restricted stock units and the subsequent surrender of 88 shares for tax obligations.

Summary

  • Christine Zayac Sheehy, SVP, Chief Human Resources Officer of Henry Schein, Inc. (HSIC), reported transactions related to her beneficial ownership.
  • On February 27, 2026, 780 shares of Common Stock, par value $0.01 per share, vested from a performance-based restricted stock/unit grant.
  • Following this vesting, 88 shares of Common Stock were surrendered to the Issuer to satisfy tax withholding obligations at a price of $82.39 per share.
  • The actual vesting date of March 1, 2026, was a non-business day, so vesting occurred on the preceding business day, February 27, 2026.
  • After these transactions, Sheehy beneficially owns 11,830 shares of Henry Schein Common Stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting the successful vesting of performance-based awards, which implies the company met its targets. The transaction is routine and expected for executive compensation.

Positives

  • Vesting of 780 performance-based restricted stock units indicates the achievement of performance criteria.
  • The reporting person's beneficial ownership remains substantial at 11,830 shares, aligning management's interests with shareholders.

Negatives

  • 88 shares were surrendered to cover tax withholding, representing a reduction in direct share ownership.

Future Outlook

This Form 4 does not contain forward-looking statements or guidance. It reports past transactions.

Industry Context

StockSavvy.ai notes that routine insider transaction filings like this Form 4 are common and reflect standard executive compensation practices involving restricted stock units. The vesting of performance-based awards suggests the company met certain internal or market-based targets, which is generally a positive indicator for the underlying business performance during the grant period.

Comparison to Industry Standards

  • These transactions are standard for executive compensation in publicly traded companies, particularly for performance-based restricted stock units. Companies like Johnson & Johnson (JNJ) or Medtronic (MDT) in the healthcare sector also frequently use similar equity compensation structures for their executives, where a portion of vested shares is withheld to cover tax liabilities. The specific number of shares and the vesting schedule are unique to Henry Schein's compensation plan and the executive's role.

Stakeholder Impact

  • Shareholders: The vesting of performance-based awards suggests management's performance aligns with shareholder interests, as these awards are typically tied to company performance metrics.
  • Employees: Reflects standard executive compensation practices, which can influence broader employee compensation strategies and morale.

Key Dates

DateDescription
03/01/2023Grant date of performance-based restricted stock/units.
02/27/2026Transaction date for vesting of restricted stock units and tax withholding.
03/01/2026Actual vesting date (non-business day, so vesting occurred on 02/27/2026).
03/03/2026Signature date of the filing.

Recommendation

hold

This Form 4 filing details a routine executive compensation event involving the vesting of restricted stock units and subsequent tax withholding. It does not provide new fundamental information about the company's financial performance or strategic direction that would warrant a change in investment recommendation. It confirms the executive's continued equity ownership, aligning interests, but offers no strong buy or sell signal.

Keywords

Henry Schein, HSIC, Form 4, Insider Transaction, Stock Vesting, Restricted Stock Units, Tax Withholding, Christine Zayac Sheehy, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.